Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01638507 · ClinicalTrials.gov registry record · NA
An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System
A NA study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT01638507 is a NA study that has completed, run by Medtronic Vascular. The registered enrollment target is 230 participants.
The verdict
NCT01638507, a NA study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
The purpose of this post approval study is to conduct a prospective, multicenter evaluation of the procedural and clinical outcomes of subjects that are treated with the commercially available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System.
Interventions
- DEVICE Resolute Integrity Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01638507
The ClinicalTrials.gov registry entry for NCT01638507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Resolute Integrity Stent is the first listed.
NCT01638507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01638507 about?
NCT01638507 is a clinical study titled "An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System". The purpose of this post approval study is to conduct a prospective, multicenter evaluation of the procedural and clinical outcomes of subjects that are treated with the commercially available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System.
What is the current status of trial NCT01638507?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2012-07. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01638507?
The interventions under investigation include: Resolute Integrity Stent (DEVICE).
Who is sponsoring clinical trial NCT01638507?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.